NAUT logo

Nautilus Biotechnology (NAUT)

Profile

Full Name

Nautilus Biotechnology, Inc.

Ticker Symbol

NAUT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 7, 2020

Indexes

Not included

Website

http://www.nautilus.bio

Employees

155

Key Details

Price

$0.77(-1.53%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.56(-9.80% YoY)

PE ratio

-

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.77
NAUT price is $0.77

30-Day Relative Volume

0.43
NAUT 30-day relative volume is 0.43

Price Performance

Price Most recent change

-1.53%
NAUT price was down -1.53% on Apr 15, 2025

Price YTD change

-54.17%
NAUT price is down -54.17% since January 1st

Price 1-year change

-68.7%
NAUT price is down -68.7% year-on-year

Price 3-year change

-80.99%
NAUT price is down -80.99% over the past 3 years

Price Range

Price All-time high

$25.89
NAUT price is currently -97.03% below its historical high of $25.89

Price 3-year low

$0.66
NAUT price is currently +16.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$97.13M
NAUT market capitalization is $97.13 million

Market cap 3-year change

-80.73%
NAUT market capitalization is down -80.73% over the past 3 years

Market cap All-time high

$1.36B
NAUT market capitalization is currently -92.88% below its historical high of $1.36 billion

Market cap sector rank

48.36%
NAUT market capitalization is higher than 48.36% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.71%
NAUT shares outstanding is up +0.71% year-on-year

Shares Outstanding 3-Year Change

+1.36%
NAUT shares outstanding is up +1.36% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.82
NAUT beta is 1.82

200-day SMA

$2.09
NAUT price is currently -63.23% below its 200-day simple moving average

50-day SMA

$1.19
NAUT price is currently -35.11% below its 50-day simple moving average

RSI

38.31
NAUT 14-day relative strength index is 38.31

Volume

0.43
NAUT 30-day relative volume is 0.43

ATR

$0.10
NAUT average true range is $0.10

10-day Historical Volatility

167.96%
NAUT 10-day historical volatility is 167.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
NAUT annual revenue value is unknown

Revenue Analysts estimate

-
NAUT annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
NAUT annual revenue 1-year change is unknown

Revenue Sector rank

-
NAUT annual revenue is unknown

EPS

EPS

-$0.56
NAUT annual earnings per share is -$0.56

EPS Analysts estimate

-$0.57
NAUT annual earnings per share is currently -1.18% lower than the consensus analysts' forecast

EPS 1-year change

-9.8%
NAUT annual earnings per share is down -9.8% year-on-year

EPS Sector rank

66.86%
NAUT annual earnings per share is higher than 66.86% of companies in Healthcare sector

Profit

Gross profit

-
NAUT annual gross profit value is unknown

Gross margin

-
NAUT annual gross profit margin value is unknown

Operating profit

-$81.48M
NAUT annual operating income is -$81.48 million

Operating margin

-
NAUT annual operating profit margin value is unknown

Net income

-$70.78M
NAUT annual net profit is -$70.78 million

Net margin

-
NAUT annual net profit margin value is unknown

Expenses

Total expenses

$81.48M
NAUT annual total expenses is $81.48 million

Operating expenses

$81.48M
NAUT annual total operating expenses is $81.48 million

Cost of goods sold

-
NAUT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$31.00M
NAUT annual SGA is $31.00 million

Depreciation and amortization

$6.35M
NAUT annual depreciation & amortization is $6.35 million

Interest expense

-
NAUT annual interest expense value is unknown

Income tax

-
NAUT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$81.48M
NAUT annual earnings before interest & taxes is -$81.48 million

EBITDA

-$75.12M
NAUT annual EBITDA is -$75.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$242.74M
NAUT annual total assets is $242.74 million

Non current assets

$109.92M
NAUT annual long term assets is $109.92 million

Current assets

$132.83M
NAUT annual total current assets is $132.83 million

Cash and cash equivalents

$27.65M
NAUT annual cash & cash equivalents is $27.65 million

Accounts receivable

-
NAUT annual accounts receivable value is unknown

Inventory

-
NAUT annual inventory value is unknown

Liabilities

Total liabilities

$34.01M
NAUT annual total liabilities is $34.01 million

Long term liabilities

$26.38M
NAUT annual total long term liabilities is $26.38 million

Current liabilities

$7.63M
NAUT annual total current liabilities is $7.63 million

Accounts payable

$987.00K
NAUT annual accounts payable is $987.00 thousand

Debt

Total debt

$30.48M
NAUT annual total debt is $30.48 million

Total debt 1-year change

-11.98%
NAUT annual total debt is down -11.98% year-on-year

Long term debt

$26.38M
NAUT annual long term debt is $26.38 million

Short term debt

$4.10M
NAUT annual short term debt is $4.10 million

Equity & Capital

Shareholders equity

$208.73M
NAUT annual stockholders equity is $208.73 million

Book value

$208.73M
NAUT annual book value is $208.73 million

Retained earnings

-$273.02M
NAUT annual retained earnings is -$273.02 million

Working capital

$125.19M
NAUT annual working capital is $125.19 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$59.15M
NAUT annual cash flow from operations is -$59.15 million

Cash from operations 1-year change

-14.38%
NAUT annual cash flow from operations is down -14.38% year-on-year

Cash from investing

$66.25M
NAUT annual cash flow from investing activities is $66.25 million

Cash from investing 1-year change

+251.48%
NAUT annual cash flow from investing activities is up +251.48% year-on-year

Cash from financing

$1.14M
NAUT annual cash flow from financing activities is $1.14 million

Cash from financing 1-year change

+210.87%
NAUT annual cash flow from financing activities is up +210.87% year-on-year

CAPEX

CAPEX

-
NAUT annual capital expenditures value is unknown

CAPEX 1-year change

-
NAUT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$61.27M
NAUT annual free cash flow is -$61.27 million

Free cash flow 1-year change

-13.14%
NAUT annual free cash flow is down -13.14% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NAUT annual gross profit margin value is unknown

Operating margin

-
NAUT annual operating profit margin value is unknown

Net margin

-
NAUT annual net profit margin value is unknown

ROA & ROE

ROA

-29.16%
NAUT annual return on assets is -29.16%

ROE

-33.91%
NAUT annual return on equity is -33.91%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NAUT price to earnings ratio value is unknown

PE ratio Sector rank

-
NAUT price to earnings ratio is unknown

PB Ratio

PB ratio

0.47
NAUT price to book ratio is 0.47

PB ratio Sector rank

28.97%
NAUT price to book ratio is higher than 28.97% of companies in Healthcare sector

PS Ratio

PS ratio

-
NAUT price to sales ratio value is unknown

PS ratio Sector rank

-
NAUT price to sales ratio is unknown

Enterprise value

Enterprise value

$99.97M
NAUT enterprise value is $99.97 million

Enterprise value Sector rank

50.29%
NAUT enterprise value is higher than 50.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.33
NAUT EV/EBITDA is -1.33

EV/EBITDA Sector rank

38.82%
NAUT EV/EBITDA is higher than 38.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

17.40
NAUT annual current ratio is 17.40

Quick ratio

-
NAUT annual quick ratio value is unknown

Leverage

Debt to equity

0.15
NAUT annual debt to equity ratio is 0.15

Interest coverage ratio

-
NAUT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NAUT piotroski f-score value is unknown

Altman Z-Score

-
NAUT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 5, 24 Goldman Sachs
Sell
Jun 27, 24 Guggenheim
Buy
Aug 3, 23 Morgan Stanley
Equal-Weight
Aug 3, 22 Morgan Stanley
Equal-Weight
Aug 3, 22 Goldman Sachs
Neutral
Jul 14, 22 Goldman Sachs
Neutral
Apr 13, 22 Goldman Sachs
Neutral
Jan 6, 22 Morgan Stanley
Equal-Weight
Nov 2, 21 Cowen & Co.
Outperform
Aug 4, 21 Goldman Sachs
Neutral

Institutional Ownership

Similar stocks

XBIT logo
XBiotech (XBIT)
LCTX logo
Lineage Cell Therapeutics (LCTX)
eXoZymes (EXOZ)
AIRS logo
AirSculpt Technologies (AIRS)
RPID logo
Rapid Micro Biosystems (RPID)
Invizyne Technologies (IZTC)
SNTI logo
Senti Biosciences (SNTI)
MGRM logo
Monogram Orthopaedics (MGRM)
IMUX logo
Immunic (IMUX)
  • What is the ticker symbol for Nautilus Biotechnology?
  • Does Nautilus Biotechnology pay dividends?
  • What sector is Nautilus Biotechnology in?
  • What industry is Nautilus Biotechnology in?
  • What country is Nautilus Biotechnology based in?
  • When did Nautilus Biotechnology go public?
  • Is Nautilus Biotechnology in the S&P 500?
  • Is Nautilus Biotechnology in the NASDAQ 100?
  • Is Nautilus Biotechnology in the Dow Jones?
  • When was Nautilus Biotechnology's last earnings report?
  • When does Nautilus Biotechnology report earnings?
  • Should I buy Nautilus Biotechnology stock now?

What is the ticker symbol for Nautilus Biotechnology?

The ticker symbol for Nautilus Biotechnology is NASDAQ:NAUT

Does Nautilus Biotechnology pay dividends?

No, Nautilus Biotechnology does not pay dividends

What sector is Nautilus Biotechnology in?

Nautilus Biotechnology is in the Healthcare sector

What industry is Nautilus Biotechnology in?

Nautilus Biotechnology is in the Biotechnology industry

What country is Nautilus Biotechnology based in?

Nautilus Biotechnology is headquartered in United States

When did Nautilus Biotechnology go public?

Nautilus Biotechnology's initial public offering (IPO) was on August 7, 2020

Is Nautilus Biotechnology in the S&P 500?

No, Nautilus Biotechnology is not included in the S&P 500 index

Is Nautilus Biotechnology in the NASDAQ 100?

No, Nautilus Biotechnology is not included in the NASDAQ 100 index

Is Nautilus Biotechnology in the Dow Jones?

No, Nautilus Biotechnology is not included in the Dow Jones index

When was Nautilus Biotechnology's last earnings report?

Nautilus Biotechnology's most recent earnings report was on Feb 27, 2025

When does Nautilus Biotechnology report earnings?

The next expected earnings date for Nautilus Biotechnology is Apr 30, 2025

Should I buy Nautilus Biotechnology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page